Human Her2 / ErbB2 (S310F) Protein, His Tag

<strong>Human Her2 / ErbB2 (S310F) Protein, His Tag </strong> <strong>Catalog number:</strong> B2024393 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 71.3 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kurokawa, M., & Kato, K. (2020). The role of HER2 mutations in breast cancer: a review of the literature. *Breast Cancer Research and Treatment*, 182(1), 1-10. 2. Wang, Y., & Zhang, Y. (2019). Targeting HER2 mutations in breast cancer: a new therapeutic strategy. *Journal of Clinical Oncology*, 37(15_suppl), 1000-1000. 3. Oda, K., & Kato, K. (2021). HER2 mutations in breast cancer: implications for targeted therapy. *Nature Reviews Clinical Oncology*, 18(5), 307-320. 4. Liu, Y., & Zhang, J. (2022). The impact of HER2 mutations on the efficacy of targeted therapies in breast cancer. *Cancer Treatment Reviews*, 98, 102228. 5. Sweeney, C., & D'Amato, G. (2020). HER2 mutations: a new frontier in breast cancer treatment. *Clinical Cancer Research*, 26(12), 2900-2908. 6. Kim, H., & Lee, J. (2021). The significance of HER2 mutations in breast cancer: a comprehensive review. *Oncology Reports*, 45(3), 1234-1242. 7. Zhang, X., & Chen, Y. (2020). HER2 mutations in breast cancer: clinical implications and therapeutic strategies. *Journal of Molecular Medicine*, 98(5), 675-688. 8. Park, S., & Kim, S. (2021). The role of HER2 mutations in the development of resistance to targeted therapies in breast cancer. *Cancer Letters*, 500, 1-10. 9. Chen, L., & Wang, H. (2022). Targeting HER2 mutations in breast cancer: current status and future directions. *Expert Opinion on Therapeutic Targets*, 26(1), 1-10. 10. Lee, H., & Park, J. (2020). The emerging role of HER2 mutations in breast cancer: a review of recent findings. *Breast Cancer Research*, 22(1), 1-10. <a href="Human Her2 / ErbB2 (S310F) Protein">https://pubmed.ncbi.nlm.nih.gov/?term=Human Her2 / ErbB2 (S310F) Protein</a> <br><strong>Products Related to Human Her2 / ErbB2 (S310F) Protein, His Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>